Reference Standardization and Analytical Performance of a Liquid Homogeneous High-density Lipoprotein Cholesterol Method Compared with Chemical Precipitation Method
Overview
Affiliations
Background: The use of high-density lipoprotein cholesterol (HDL-C) levels as a risk factor for coronary heart disease necessitates an accurate and precise method for measuring HDL-C. The Centers for Disease Control and Prevention HDL-C reference method (RM) and designated comparison method (DCM) are time-consuming, expensive, and impractical for routine clinical use. We evaluated the Liquid N-geneous (LN-gen) HDL-C assay (Genzyme Diagnostics, Cambridge, Mass) to determine if this homogeneous reagent meets the National Cholesterol Education Program requirements for HDL-C evaluation.
Design: Accuracy of the LN-gen HDL-C assay was compared in combination with phosphotungstic acid (PTA) precipitation with DCM HDL-C for normotriglyceridemic serum specimens (triglycerides < 2.0 g/L) and with RM HDL-C for specimens with triglycerides levels > or = 2.0 g/L.
Setting: Genzyme Diagnostics (with RM and DCM assayed by Pacific BioMetrics Inc, Seattle, Wash) and the Lipid Reference Laboratory of the University Hospital Rotterdam, The Netherlands.
Results: Linear regression to DCM (n = 90) was (LN-gen = 1.015 DCM + 0.01 g/L, r = 0.993, SE = 0.015 g/L) and (PTA = 1.004 DCM - 0.017 g/L, r = 0.980, SE = 0.025 g/L), with a mean percent bias to DCM of 3.3% and -2.8% for LN-gen and PTA, respectively. The comparison with RM (n = 69) showed an increased mean bias for PTA (-5.8%) as compared with LN-gen (1.5%). The correlation and regression equations were (LN-gen = 1.020 RM - 0.002 g/L, r = 0.985, SE = 0.017 g/L) and (PTA = 1.042 RM - 0.032 g/L, r = 0.984, SE = 0.018 g/L). The precision of LN-gen was confirmed at < 2.1% coefficient of variation, and the total error was calculated to be < or = 7.7% for both normotriglyceride and elevated triglyceride specimens at HDL-C decision points of 0.35 g/L and 0.60 g/L.
Conclusions: The LN-gen HDL-C assay offers a cost-effective convenient method for meeting the 1998 precision, bias, and total error recommendations of the National Cholesterol Education Program.
Miller W, Myers G, Sakurabayashi I, Bachmann L, Caudill S, Dziekonski A Clin Chem. 2010; 56(6):977-86.
PMID: 20378768 PMC: 4687457. DOI: 10.1373/clinchem.2009.142810.
Higher selenium status is associated with adverse blood lipid profile in British adults.
Stranges S, Laclaustra M, Ji C, Cappuccio F, Navas-Acien A, Ordovas J J Nutr. 2009; 140(1):81-7.
PMID: 19906812 PMC: 2793123. DOI: 10.3945/jn.109.111252.
Overestimation of HDL-cholesterol using a homogeneous "direct" assay.
Zhao W, Chaffin C, Desmond R, Hodges B, Daly T, Robinson C J Clin Lab Anal. 2004; 18(1):42-4.
PMID: 14730557 PMC: 6807988. DOI: 10.1002/jcla.20000.
Measurement of cholesterol in plasma and other body fluids.
Warnick G, Remaley A Curr Atheroscler Rep. 2001; 3(5):404-11.
PMID: 11565569 DOI: 10.1007/s11883-001-0079-7.